about
Fulfilling the promise of personalized medicine? Systematic review and field synopsis of pharmacogenetic studiesA genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin doseClinician adoption of genetic testing for drug metabolizing enzymes: is patient safety the low-hanging fruit of personalized medicine?Personalized medicine and genomics: challenges and opportunities in assessing effectiveness, cost-effectiveness, and future research priorities.Pharmacogenetics of vitamin K antagonists: useful or hype?
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Genetic testing for warfarin therapy initiation.
@en
Genetic testing for warfarin therapy initiation.
@nl
type
label
Genetic testing for warfarin therapy initiation.
@en
Genetic testing for warfarin therapy initiation.
@nl
prefLabel
Genetic testing for warfarin therapy initiation.
@en
Genetic testing for warfarin therapy initiation.
@nl
P2093
P2860
P356
P1476
Genetic testing for warfarin therapy initiation.
@en
P2093
Bonny L Bukaveckas
Lauren M Hynicka
William D Cahoon
P2860
P304
P356
10.1345/APH.1L127
P407
P577
2008-08-05T00:00:00Z